The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases
Open accessAbstract
BackgroundPatients with colorectal liver metastases (CLM) are increasingly treated with preoperative chemotherapy. Chemotherapy associated liver injury is associated with postoperative hepatic insufficiency (PHI) and mortality. The adequate minimum future liver remnant (FLR) volume in patients treated with extensive chemotherapy remains unknown.MethodsAll patients with standardized FLR > 20 %, who underwent extended right hepatectomy for CLM from 1993-2011, were divided into three cohorts by chemotherapy duration: no chemotherapy (NC, n = 30), short duration (SD, ≤12 weeks, n = 78), long duration (LD, >12 weeks, n = 86). PHI and mortality were compared by using uni-/multivariate analyses. Optimal FLR for LD chemotherapy was determined using a minimum p-value approach.ResultsA total of 194 patients met inclusion criteria. LD chemotherapy was significantly associated with PHI (NC + SD 3.7 vs. LD 16.3%, p = 0.006). Ninety-day mortality rates were 0 % in NC, 1.3 % in SD, and 2.3% in LD patients, respectively (p = 0.95). In patients with FLR > 30 %, PHI occurred in only two patients (both LD, 2/20, 10 %), but all patients with FLR > 30 % survived. The best cutoff of FLR for preventing PHI after chemotherapy >12 weeks was estimated as >30 %. Both LD chemotherapy (odds ratio [OR] 5.4, p = 0.004) and FLR ≤ 30 % (OR 6.3, p = 0.019) were independent predictors of PHI.ConclusionsPreoperative chemotherapy >12 weeks increases the risk of PHI after extended right hepatectomy. In patients treated with long-duration chemotherapy, FLR > 30 % reduces the rate of PHI and may provide enough functional reserve for clinical rescue if PHI develops.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Cited by
Vouche, M., Lewandowski, R. J., Atassi, R., Memon, K., Gates, V. L., Ryu, R. K., Gaba, R. C., Mulcahy, M. F., Baker, T., Sato, K., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.015 · Cited by 271
Current status of surgical treatment of colorectal liver metastases
Xu, F., Tang, B., Jin, T.-Q., & Dai, C.-L. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i14.716 · Cited by 45
Haddad, A., Khavandi, M. M., Lendoire, M., Acidi, B., Chiang, Y.-J., Gupta, S., Tam, A., Odisio, B. C., Mahvash, A., Abdelsalam, M. E., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-024-16558-1 · Cited by 10
Self-citation
Metadata
- Authors
- Shindoh, J., Tzeng, C.-W. D., Aloia, T. A., Curley, S. A., Zimmitti, G., Wei, S. H., Huang, S. Y., Mahvash, A., Gupta, S., Wallace, M. J., & Vauthey, J.-N.
- Venue
- Annals of Surgical Oncology
- Published
- 2013-02-03
- Volume
- 20
- Issue
- 8
- Pages
- 2493-2500
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W1993538153
- Cited by
- 193
- References
- 1
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases. https://app.cochat.ai/papers/10.1245/s10434-012-2864-7
- The paper
- Shindoh, J., Tzeng, C.-W. D., Aloia, T. A., Curley, S. A., Zimmitti, G., Wei, S. H., Huang, S. Y., Mahvash, A., Gupta, S., Wallace, M. J., & Vauthey, J.-N. (2013). Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-012-2864-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.